(Reuters) - Dentsply International Inc said on Tuesday it would buy peer Sirona Dental Systems Inc in a $5.56 billion all-stock deal, creating the world's largest dental equipment maker. Sirona ...

If you have been wondering whether DENTSPLY SIRONA is a beaten down bargain or a value trap, you are not alone. This is exactly what we are going to unpack. The stock has bounced 2.3% over the last ...

CHARLOTTE, N.C., Dec. 08, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY). Dentsply Sirona and 3Shape have taken the next step according to their agreement and now ...

Dental device maker Dentsply Sirona has a lot to smile about. This week, it unveiled two separate initiatives, both intended to support its efforts to bring dentistry thoroughly into the digital age.

Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q2 dental equipment & technology earnings season. The dental equipment and ...

DENTSPLY SIRONA has seen ongoing revenue declines, margin compression, and significant management turnover amid a challenging dental market. XRAY's new CEO has launched a two-year turnaround plan ...

In what's being billed as a merger of equals, dental device bigwigs Dentsply International ($XRAY) and Sirona Dental Systems ($SIRO) are joining forces in an all ...

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. DENTSPLY SIRONA Inc. is one of them. DENTSPLY SIRONA Inc. (NASDAQ:XRAY), the world’s largest manufacturer of ...

Throughout the last three months, 5 analysts have evaluated Dentsply Sirona (NASDAQ:XRAY), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...

Dental products manufacturer Dentsply Sirona has voluntarily suspended the sale and marketing of its Byte aligners and impression kits while it conducts a review of regulatory requirements, according ...

Dentsply Sirona (NASDAQ:XRAY) and ZimVie Inc. (NASDAQ:ZIMV) show below-market growth and have no meaningful upside, according Needham analysts. What Happened: Needham downgraded the two dental ...